Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy

Kara L. Watts, Abhishek Srivastava, Wilson Lin, Daniel Schoenfeld, Matthew K. Abramowitz, Joshua M. Stern

Research output: Contribution to journalArticle

Abstract

To compare renal functional outcomes in patients with and without chronic kidney disease (CKD) to identify predictors of change in renal function after percutaneous nephrolithotomy (PCNL). We reviewed patients who underwent PCNL by a single surgeon over 3.5 years. Patients’ pre- and post-operative Glomerular Filtration Rate (GFR) was calculated. Baseline GFR < 60 ml/min/1.73 m 2 (stage ≥ 3 CKD) defined our CKD cohort. Patients’ baseline renal function, comorbidities, stone parameters, and intra-operative variables were analyzed to determine the relationship with post-operative renal function after PCNL by multivariate analysis. 202 patients were analyzed. Mean follow-up time was 16 months. At baseline, 163 (80.7%) patients were free of CKD and 39 (19.3%) had CKD. Patients without CKD had an overall decrease in GFR from 105.6 to 103.3 ml/min/1.73 m 2 (p = 0.494). 14/163 (8.6%) non-CKD patients experienced a significant decline in renal function after PCNL; 7/163 (4.3%) developed de novo CKD and 7 had a ≥ 30% decline in GFR. Patients with CKD had an overall increase in mean GFR post-operatively, from 47.3 to 54.0 ml/min/m 2 (p = 0.067). Two in this cohort (5.1%) experienced a > 30% decline in renal function post-operatively. Age, gender, African American race, presence of comorbidities and pre-operative CKD were not significant predictors of renal function post-operatively on multivariate analysis. PCNL in this cohort appears GFR neutral in the setting of baseline CKD. CKD was not predictive of renal functional decline after PCNL. Given that stone disease carries a high recurrence rate and that CKD is associated with stone formers, further investigation into predictors of renal function change after PCNL is warranted.

Original languageEnglish (US)
JournalUrolithiasis
DOIs
StatePublished - Jan 1 2019

Fingerprint

Percutaneous Nephrostomy
Chronic Renal Insufficiency
Kidney
Glomerular Filtration Rate
African Americans
Comorbidity
Multivariate Analysis
Recurrence

Keywords

  • CKD
  • Kidney stone
  • PCNL
  • Renal function

ASJC Scopus subject areas

  • Urology

Cite this

Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy. / Watts, Kara L.; Srivastava, Abhishek; Lin, Wilson; Schoenfeld, Daniel; Abramowitz, Matthew K.; Stern, Joshua M.

In: Urolithiasis, 01.01.2019.

Research output: Contribution to journalArticle

@article{7fa59e161bde41d9a1ddcb49aa760660,
title = "Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy",
abstract = "To compare renal functional outcomes in patients with and without chronic kidney disease (CKD) to identify predictors of change in renal function after percutaneous nephrolithotomy (PCNL). We reviewed patients who underwent PCNL by a single surgeon over 3.5 years. Patients’ pre- and post-operative Glomerular Filtration Rate (GFR) was calculated. Baseline GFR < 60 ml/min/1.73 m 2 (stage ≥ 3 CKD) defined our CKD cohort. Patients’ baseline renal function, comorbidities, stone parameters, and intra-operative variables were analyzed to determine the relationship with post-operative renal function after PCNL by multivariate analysis. 202 patients were analyzed. Mean follow-up time was 16 months. At baseline, 163 (80.7{\%}) patients were free of CKD and 39 (19.3{\%}) had CKD. Patients without CKD had an overall decrease in GFR from 105.6 to 103.3 ml/min/1.73 m 2 (p = 0.494). 14/163 (8.6{\%}) non-CKD patients experienced a significant decline in renal function after PCNL; 7/163 (4.3{\%}) developed de novo CKD and 7 had a ≥ 30{\%} decline in GFR. Patients with CKD had an overall increase in mean GFR post-operatively, from 47.3 to 54.0 ml/min/m 2 (p = 0.067). Two in this cohort (5.1{\%}) experienced a > 30{\%} decline in renal function post-operatively. Age, gender, African American race, presence of comorbidities and pre-operative CKD were not significant predictors of renal function post-operatively on multivariate analysis. PCNL in this cohort appears GFR neutral in the setting of baseline CKD. CKD was not predictive of renal functional decline after PCNL. Given that stone disease carries a high recurrence rate and that CKD is associated with stone formers, further investigation into predictors of renal function change after PCNL is warranted.",
keywords = "CKD, Kidney stone, PCNL, Renal function",
author = "Watts, {Kara L.} and Abhishek Srivastava and Wilson Lin and Daniel Schoenfeld and Abramowitz, {Matthew K.} and Stern, {Joshua M.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00240-019-01113-5",
language = "English (US)",
journal = "Urolithiasis",
issn = "2194-7228",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Baseline chronic kidney disease does not predict long-term renal functional decline after percutaneous nephrolithotomy

AU - Watts, Kara L.

AU - Srivastava, Abhishek

AU - Lin, Wilson

AU - Schoenfeld, Daniel

AU - Abramowitz, Matthew K.

AU - Stern, Joshua M.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - To compare renal functional outcomes in patients with and without chronic kidney disease (CKD) to identify predictors of change in renal function after percutaneous nephrolithotomy (PCNL). We reviewed patients who underwent PCNL by a single surgeon over 3.5 years. Patients’ pre- and post-operative Glomerular Filtration Rate (GFR) was calculated. Baseline GFR < 60 ml/min/1.73 m 2 (stage ≥ 3 CKD) defined our CKD cohort. Patients’ baseline renal function, comorbidities, stone parameters, and intra-operative variables were analyzed to determine the relationship with post-operative renal function after PCNL by multivariate analysis. 202 patients were analyzed. Mean follow-up time was 16 months. At baseline, 163 (80.7%) patients were free of CKD and 39 (19.3%) had CKD. Patients without CKD had an overall decrease in GFR from 105.6 to 103.3 ml/min/1.73 m 2 (p = 0.494). 14/163 (8.6%) non-CKD patients experienced a significant decline in renal function after PCNL; 7/163 (4.3%) developed de novo CKD and 7 had a ≥ 30% decline in GFR. Patients with CKD had an overall increase in mean GFR post-operatively, from 47.3 to 54.0 ml/min/m 2 (p = 0.067). Two in this cohort (5.1%) experienced a > 30% decline in renal function post-operatively. Age, gender, African American race, presence of comorbidities and pre-operative CKD were not significant predictors of renal function post-operatively on multivariate analysis. PCNL in this cohort appears GFR neutral in the setting of baseline CKD. CKD was not predictive of renal functional decline after PCNL. Given that stone disease carries a high recurrence rate and that CKD is associated with stone formers, further investigation into predictors of renal function change after PCNL is warranted.

AB - To compare renal functional outcomes in patients with and without chronic kidney disease (CKD) to identify predictors of change in renal function after percutaneous nephrolithotomy (PCNL). We reviewed patients who underwent PCNL by a single surgeon over 3.5 years. Patients’ pre- and post-operative Glomerular Filtration Rate (GFR) was calculated. Baseline GFR < 60 ml/min/1.73 m 2 (stage ≥ 3 CKD) defined our CKD cohort. Patients’ baseline renal function, comorbidities, stone parameters, and intra-operative variables were analyzed to determine the relationship with post-operative renal function after PCNL by multivariate analysis. 202 patients were analyzed. Mean follow-up time was 16 months. At baseline, 163 (80.7%) patients were free of CKD and 39 (19.3%) had CKD. Patients without CKD had an overall decrease in GFR from 105.6 to 103.3 ml/min/1.73 m 2 (p = 0.494). 14/163 (8.6%) non-CKD patients experienced a significant decline in renal function after PCNL; 7/163 (4.3%) developed de novo CKD and 7 had a ≥ 30% decline in GFR. Patients with CKD had an overall increase in mean GFR post-operatively, from 47.3 to 54.0 ml/min/m 2 (p = 0.067). Two in this cohort (5.1%) experienced a > 30% decline in renal function post-operatively. Age, gender, African American race, presence of comorbidities and pre-operative CKD were not significant predictors of renal function post-operatively on multivariate analysis. PCNL in this cohort appears GFR neutral in the setting of baseline CKD. CKD was not predictive of renal functional decline after PCNL. Given that stone disease carries a high recurrence rate and that CKD is associated with stone formers, further investigation into predictors of renal function change after PCNL is warranted.

KW - CKD

KW - Kidney stone

KW - PCNL

KW - Renal function

UR - http://www.scopus.com/inward/record.url?scp=85061455918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061455918&partnerID=8YFLogxK

U2 - 10.1007/s00240-019-01113-5

DO - 10.1007/s00240-019-01113-5

M3 - Article

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

ER -